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Abstract
Background: Environmental control to reduce the amount of allergens in a living place is thought to be important
to avoid sensitization to airborne allergens. However, efficacy of environmental control on inactivation of airborne
allergens is not fully investigated. We have previously reported that positively- and negatively-charged plasma
cluster ions (PC-ions) reduce the IgE-binding capacity of crude allergens from Japanese cedar pollen as important
seasonal airborne allergens. Cat (Felis domesticus) and fungus (Aspergillus fumigatus) are also important sources of
common airborne allergens in living spaces throughout the year, and early sensitization with those allergens is
considered to be a risk factor for future development of allergic rhinitis, pollinosis and asthma. The aim of this study
is to examine whether the PC-ions reduce the IgE-binding capacity of a cat major allergen (Fel d 1) and fungal
allergens in an experimental condition.
Methods: Fel d 1, crude fungal extract, or a fungal major allergen Asp f 1, was treated with PC-ions for 6 h in an
experimental cylindrical apparatus. Sham-treated allergens were prepared in the same experimental apparatus
without generation of PC-ions. The degradation of the PC-ions-treated Fel d 1 was analyzed by SDS-PAGE, and the
IgE-binding capacity of the PC-ions-treated allergens was analyzed by ELISA inhibition assay.
Results: Exposure of Fel d 1, crude fungal extract and Asp f 1 to PC-ions significantly decreased protein content of Fel
d 1 or Asp f 1, respectively. SDS-PAGE analysis suggested that the decreased Fel d 1 content upon exposure with
PC-ions was attributable to protein degradation. ELISA inhibition indicated that the PC-ions treatment significantly
impaired IgE-binding capacities of Fel d 1, crude fungal allergens, and Asp f 1 compared to sham treatment.
Discussion: Our data suggest that treatment with PC-ions not only reduce indoor cat and fungal allergens, but also
impair their allergenicity.
Conclusion: These results suggest that environmental control with PC-ions is useful for inactivation of indoor cat and
fungal allergens.
Keywords: Airborne allergen, Asp f 1, Asthma, Cat allergen, Environmental control, Fel d 1, Fungal allergen,
Immunoglobulin E, Positively- and negatively-charged cluster ions
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Background
High amounts of airborne allergens that can be found in
living spaces can be a risk factor for sensitization to al-
lergens and elicitation of allergic symptoms, such as
rhinitis and asthmatic attacks. Environmental control to
clean air pollutants can lead to the amelioration of aller-
gic symptoms. Moreover, environmental control using
an air filtration unit resulted in the significant reduction
of the quantity of inhaled airborne allergens in a room.
Such reductions in the amounts of airborne allergen
may result in positive impacts that can improve clinical
symptoms [1, 2]. We previously reported that environ-
mental control using an air cleaner with positively- and
negatively-charged plasma cluster ions (PC-ions) in-
duced protein degradation and inactivation of atomized
Japanese cedar (Cryptomeria japonica) pollen allergens
[3]. Therefore, we hypothesized that PC-ions might also
degrade and inactivate common airborne allergens. In
this study, we focused on cat and fungal allergens as
common indoor airborne allergens, because cats and
fungal allergens represent a significant risk factor to in-
duce respiratory disorders including asthmatic attacks
throughout the year [4, 5]. It is more important to inves-
tigate PC-ions can inactivate perennial airborne allergens
than seasonal allergens for allergic patients. Therefore,
we analyzed whether the PC-ions can impair IgE-
binding capacity of a cat major allergen, Fel d 1, and
fungal allergens as important environmental airborne al-
lergens to induce allergic rhinitis and asthma attacks
throughout the year.
Cat (Felis domesticus) allergens represent some of the
most important airborne allergens that can induce se-
vere allergic rhinitis and asthma. Sensitization to cat al-
lergens in childhood is thought to be a risk factor for the
future development of pollinosis, asthma, and allergic
eczema [4, 6]. In Japan, a survey of 504 asthma patients
conducted in 1993–1994 reported that 70 % of 44 pa-
tients who kept cats and 34 % of 394 patients who had
never kept cats were positive for cat-specific IgE, as indi-
cated by CAP-RAST score ≥2 [7]. Notably, individuals
who never had a cat can also be sensitized to airborne
cat allergens as a consequence of exposure to airborne
cat allergens outdoors and in public institutions. Cat al-
lergens have been detected in school classrooms in the
absence of cats; furthermore, indoor airborne pollutants
are more toxic than those that are found outdoors, and
these could induce inflammatory and allergic reactions
[8]. Airborne cat allergens are thought to be transferred
and deposited indoors when attached on the clothes or
hair of cat owners [9]. Therefore, sensitization to cat al-
lergens can occur in individuals who do not keep a cat.
Feline uteroglobin was identified as a major allergen for
cat allergy and was termed Fel d 1 [10]. Fel d 1 is a tetra-
meric glycoprotein that is formed by two heterodimers and
has an apparent ~38 kDa molecular weight. The heterodi-
mer is composed of two separate chains with apparent mo-
lecular weight of 4–5 and 14–20 kDa under denatured
condition, as chain 1 and chain 2, respectively [11, 12]. Im-
munoblotting analysis showed both chain 1 and chain 2
had IgE-binding capacity with cat-allergic patients’ sera and
the IgE-binding frequency was 100 % (6/6) and 33 % (2/6)
for the chain 1 and chain 2, respectively, in six cat-allergic
patients’ IgE. The chain 1 and chain 2 were dissociated in
native Fel d 1 after denaturation by such high pH condition
or reduced condition with SDS [12]. IgE titers specific to
Fel d 1 in cat-sensitized asthma patients were significantly
higher than those in cat-sensitized rhinitis patients. There-
fore, elevated titers of Fel d 1-specific IgE are thought to be
a risk factor for asthma in children who are allergic to cats
[13]. These reports showed the immunological importance
of Fel d 1 as a major allergen related to cat allergy.
Allergenic fungus (Aspergillus fumigatus) is also an im-
portant source of airborne allergens and has been a major
course of allergic bronchopulmonary aspergillosis. Twenty
three allergens from A. fumigatus have registered on the
official website for the systematic allergen nomenclature
that is approved by the World Health Organization and
International Union of Immunological Societies (WHO/
IUIS) Allergen Nomenclature Sub-committee. Asp f 1 and
Asp f 2 are reported to be major allergens for A. fumigatus
among the registered allergens [14]. Asp f 1 has identified
as an IgE-binding protein belonged to mitogillin family of
cytotoxins from A. fumigatus. Asp f 1 is an 18 kDa protein
with 85 % (11/13) IgE-binding frequency within asthma or
allergic bronchopulmonary aspergillosis patients [15]. Air-
borne fungal allergen exposures increase degree of atopy
and visit to emergency department or urgent care for
asthma [5]. Environmental control including decrease of
airborne fungal allergens is considered to be important to
reduce the incidence of asthma attacks for both childhood
and adult asthma.
Herein, we showed the degradation and impairment of
IgE-binding capacity of Fel d 1, crude fungal allergen, and
Asp f 1 by PC-ions in experimental cylindrical condition.
Methods
Reagents and plasma
A cat major allergen, Fel d 1, and a fungal major allergen,
Asp f 1, were purchased from INDOOR Biotechnologies
(Charlottesville, VA, USA). Crude fungal extract (CFE) was
purchased from ITEA (Tokyo, Japan). All chemicals were
purchased from Katayama Chemical Industries (Osaka,
Japan), Sigma-Aldrich (St. Louis, MO, USA) or Nacalai
Tesque (Kyoto, Japan) unless otherwise indicated. Plasma
was obtained from two cat-allergic asthma patients who
exhibited positive CAP-RAST score to Fel d 1 and from
three fungi-allergic asthma patients who showed positive
CAP-RAST score to Asp f 1. The plasma were stored at
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−30 °C until use. All studies that used human samples
were approved by the institutional ethics committee at
Showa University School of Medicine (Tokyo, Japan).
Treatment of positively- and negatively-charged plasma
cluster ions
Airborne allergens; Fel d 1, CFE and Asp f 1, were treated
with positively- and negatively-charged plasma cluster
ions (PC-ions), as described previously [3]. Briefly, a cylin-
drical apparatus (14.5 cm diameter × 52.5 cm height) was
filled with PC-ions (2.5 × 104 PC-ions/cm3) for 6 h, and
then 221 mL of 1 mg/ml Fel d 1 solution or 666 ml of
40 ng/ml CFE or Asp f 1 solution was nebulized from top
of the apparatus to expose the PC-ions. Nebulized solu-
tion was collected in a 10 cm petri dish (BD Biosciences,
San Diego, CA, USA) that was placed underneath the ap-
paratus (Fig. 1). Sham-treated allergen was prepared in the
same condition, but without generating the PC-ions.
Quantification of Fel d 1 and Asp f 1 by ELISA and mass
spectrometric analysis
Amount of Fel d 1 and Asp f 1 was quantified using a Fel
d 1- or Asp f 1-specific enzyme-linked immunosorbent
assay (ELISA) kit (INDOOR Biotechnologies) following
the manufacturer’s instructions. Prior to quantification of
Fel d 1 by ELISA, CFE and Fel d 1 solution after PC-ions
or sham treatment were 1,250-fold concentrated by
lyophilization. Fel d 1 that was collected after PC-ions or
sham treatment was separated by sodium dodecyl sulfate
polyacrylamide gel electrophoresis (SDS-PAGE) under
reducing condition and proteins were visualized by silver
staining following the manufacturer’s instructions (Cosmo
Bio, Tokyo, Japan). Proteins separated on SDS-PAGE were
identified by liquid chromatography (LC) connected to a
mass spectrometer (MS, LTQ Orbitrap XL, Thermo Fisher
Scientific, Rockford, IL, USA) using a HPLC column
(Develosil ODS-HG-5, Nomura Chemical, Aichi, Japan)
and Xcalibur software v2.0.7 (Thermo Fisher Scientific), as
described elsewhere [16].
ELISA inhibition
The immunoglobulin E (IgE)-binding capacity of PC-ions-
treated allergens for pooled plasma from patients sensitized
with each allergen was analyzed using an ELISA inhibition
assay, as described previously with slight modifications [3].
Briefly, a 96-well microtiter plate (NUNC maxisorp,
Thermo Fisher scientific) was coated with 0.1 ml of
200 ng/ml sham-treated Fel d 1, CFE or Asp f 1 dissolved
in 100 mM bicarbonate buffer (pH 9.4) overnight at 4 °C.
After washing three times with phosphate buffered saline
containing 0.05 % Tween 20 (PBST), plate were blocked
with PBST containing 3 % skim milk and 1 % bovine serum
albumin (BSA) for 2 h. Pooled plasma was diluted 80-fold
from two Fel d 1-positive asthmatic patients or 12.5-fold
from three Asp f 1-positive asthmatic patients, which was
preincubated with serial dilutions of PC-ions- or sham-
treated Fel d 1, CFE or Asp f 1 overnight at 4 °C. Then,
pooled plasma was applied to sham-treated Fel d 1-, CFE-
or Asp f 1-coated plates, which were incubated for 12 h at
4 °C. After washing with PBST three times, plates were in-
cubated with biotinylated anti-human IgE monoclonal anti-
body (Vector Laboratories, Burlingame, CA, USA) diluted
1:1,000 for 1 h at room temperature, followed by 1 h incu-
bation with alkaline phosphate-conjugated streptavidin
(Jackson ImmunoResearch Laboratories, West Grove, PA,
USA). To determine the amount of IgE-binding, Attophos
substrate solution (Promega, Fitchburg, WI, USA) was
added to the plate and fluorescence intensity was measured
using a Wallac 1420 ARVOsx Multilabel Counter (Perkin-
Elmer, Downers Grove, IL, USA).
Statistical analysis
Statistical analyses were performed using non-repeated
ANOVA. For differences that were found to be signifi-
cant, post-hoc analysis using a Student-Newman-Keuls
test was performed. A threshold for statistical signifi-
cance was set at P < 0.01.
Results
PC-ions decrease protein content of a cat major allergen,
Fel d 1
We previously reported that PC-ions inactivated the aller-
genic activity of crude allergen extracted from Japanese
cedar (Cryptomeria japonica) pollen [3]. This finding
Fig. 1 Cylindrical apparatus for PC-ions exposure. PC-ions were
generated in four Plasma cluster™ devices (shown as gray boxes)
that were placed inside of wall of the apparatus. PC-ions were emitted
from the devices and filled the apparatus at 2.5 × 104 ions/cm3. A “mist”
solution containing allergen was generated from a nebulizer located
on the top of the apparatus, which is shown in a box with horizontal
stripe. The solution was shed at 2.5 L/min (flow rate) and 3.3 m/s (linear
velocity). A petri dish was placed beneath the apparatus to collect the
PC-ions- or sham-treated allergen solution
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prompted us to investigate whether PC-ions could also in-
activate the IgE-binding activity of cat and fungal aller-
gens, as these are among the most important airborne
indoor allergens that can induce severe allergic rhinitis
and asthma attacks. After treatment with PC-ions, the
concentration of Fel d 1 was significantly reduced com-
pared with those measured before treatment and after
sham treatment (351.1, 52.6, and 11.4 ng/ml for before
treatment, after sham and PC-ions treatments, respect-
ively; Fig. 2a). Concentration of Fel d 1 after sham treat-
ment was also significantly reduced compared with that
before treatment. The reduction was thought to be a con-
sequence of non-specific degradation by vaporization of
solution in the apparatus (Fig. 1). Indeed, the concentra-
tion of Fel d 1 was reduced by 79.3 % after PC-ions treat-
ment compared with that after sham treatment. SDS-
PAGE analysis indicated that both the 16.0 kDa (chain 2)
and 6.5 kDa (chain 1) proteins were significantly reduced
after PC-ions treatment compared with those before treat-
ment and after sham treatment (Fig. 2c). We confirmed
that the 16.0 and 6.5 kDa proteins were subunits of Fel d
1 by analyzing of internal amino acid sequences after tryp-
sin digestion using LC-MS (data not shown).
PC-ions impair the IgE-binding capacity of Fel d 1
We then analyzed the IgE-binding capacity of Fel d 1
after PC-ions or sham treatment. We tested IgE-binding
capacity of PC-ions-treated Fel d 1 by inhibitory activity
between sham-treated Fel d 1 and a pooled plasma from
Fel d 1-positive patients, as only nebulization could reduce
IgE-binding capacity for Fel d 1, as suggested by the pro-
tein degradation analysis (Fig. 2a and c). The inhibition
curve for Fel d 1 after PC-ions treatment was shifted to-
wards a higher allergen dose compared with that of sham
treatment (Fig. 3a). The amount of protein needed achieve
50 % inhibition of binding between sham-treated-Fel d 1
and pooled plasma was 53.5 and 12.4 ng for PC-ions- and
sham-treated Fel d 1, respectively. This finding showed
76.9 % of IgE-binding capacity was impaired by PC-ions
treatment. These data strongly suggested that PC-ions
inactivated indoor cat allergens by degrading Fel d 1.
A
C
B
Fig. 2 Degradation of Fel d 1 and CFE after PC-ions treatment. Concentrations of Fel d 1 (a) or Asp f 1 contained in CFE (b) in solution before and after
sham or PC-ions treatment, as measured by ELISA, are represented as pre-treated, sham-treated and ion-treated, respectively. Concentrations of allergens
are represented as means ± standard deviation. Significant differences at the level of **P< 0.01 was estimated by the post-hoc Student-Newman-Keuls
test after non-repeated ANOVA. c Solutions of Fel d 1 before treatment and collected in the petri dish after sham or PC-ions treatment were loaded on a
SDS-PAGE gel under reducing condition, which were labeled as pre-treated, sham-treated, and ion-treated, respectively. After visualizing bands by silver
staining, the amino acid sequences of the main 15.0 and 6.5 kDa bands (chain 2 and chain 1, respectively) were analyzed by LC-MS and were confirmed
to match the amino acid sequence of Fel d 1. Chain 1 and chain 2 for Fel d 1 were indicated with arrows. The lane labeled as Marker
represents a molecular weight marker
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PC-ions also impair the IgE-binding capacity of fungal
allergens
We also analyzed the impairment of IgE-binding cap-
acity of fungal allergens by PC-ions treatment. The
amount of Asp f 1 in CFE after both sham and PC-ions
treatments was significantly decreased compared with
that before treatment as same as the case of Fel d 1, and
the amount of Asp f 1 after PC-ions treatment was signifi-
cantly reduced compared with that after sham treatment
(1.97, 0.38 and 0.14 pg/ml before treatment and after
sham or PC-ions treatment, respectively; Fig. 2b). We also
nebulized a purified Asp f 1 in the cylindrical apparatus.
The amount of the Asp f 1 was also significantly decreased
after nebulizing in the apparatus as well as the case of
CFE, however, the amount of Asp f 1 after PC-ions treat-
ment was comparable with that after sham treatment (6.1,
1.9 and 1.7 ng/ml before treatment and after sham or PC-
ions treatment, respectively; data not shown).
We then analyzed IgE-binding capacity of CFE and Asp
f 1after PC-ions treatment. The inhibition curve for PC-
ions-treated CFE was shifted to high dose of inhibitors
compared to sham-treated CFE (Fig. 3b). The amount of
inhibitors to achieve 50 % inhibition of sham-treated CFE
and a pooled plasma were 159 ng for sham-treated CFE
and 601 ng for PC-ions-treated CFE, respectively (Fig. 3b).
The result showed 73.5 % reduction of IgE-binding
capacity by PC-ions treatment for CFE. To confirm the in-
activation of IgE-binding capacity of Asp f 1 by PC-ions,
IgE-binding capacity of Asp f 1 after PC-ions treatment
was analyzed. For the inhalation as a purified Asp f 1, the
amount of inhibitors to achieve 50 % inhibition of sham-
and PC-ions-treated Asp f 1 were 1.99 ng for sham treat-
ment and 10.93 ng for PC-ions treatment, respectively
(Fig. 3c). The result showed 81.8 % reduction of IgE-
binding capacity after PC-ions treatment and this reduc-
tion was comparable with that for CFE.
Discussion
Sensitization to cat allergens in childhood represents a
strong risk factor for developing pollinosis, asthma, and
atopic eczema in school children and adults [4]. To avoid
sensitization to cat allergens, it is not sufficient to avoid
keeping or approaching a cat, because airborne cat aller-
gens can be carried with clothes and hairs of cat-owners
into kindergartens, school class rooms, and public institu-
tions [9]. We found that PC-ions could effectively degrade
and inactivate an airborne cat allergen, Fel d 1 (Figs. 2a, c
and 3a). PC-ions significantly degraded both chain 1 and
chain 2 for Fel d 1 and the chain 2 disappeared almost
completely after PC-ions treatment by SDS-PAGE analysis
(Fig. 2c). Degradation and modification of the tertiary
A
C
B
Fig. 3 Impairment of IgE-binding capacity of Fel d 1, CFE and Asp f 1 after PC-ions treatment. The IgE-binding capacity of Fel d 1 (a), CFE (b) or
Asp f 1 (c) after PC-ions treatment was analyzed by ELISA inhibition assay. Inhibition of binding between a pooled plasma from patients and
sham-treated Fel d 1, CFE or Asp f 1 was analyzed using sham- and PC-ions-treated Fel d 1, CFE or Asp f 1, shown as open diamonds with a
broken line (sham-treated) and filled circles with a line (ion-treated), respectively
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structure of Fel d 1 by PC-ions may also significantly lead
to the impairment of its IgE-binding capacity.
PC-ions treatment of purified Asp f 1 also impaired IgE-
binding capacity of Asp f 1, although exposure with PC-
ions had no significant effect on the protein amount of Asp
f 1 as quantified by sandwich ELISA (Fig. 3c and data not
shown). Our ELISA inhibition assay showed that PC-ions
treatment impaired IgE-binding capacity for CFE and puri-
fied Asp f 1, which indicated that 73.5 % and 81.8 % of their
IgE-binding capacities were lost upon exposure to PC-ions
(Fig. 3b and c). These degree of impaired IgE-binding cap-
acity were comparable to that seen in PC-ions-treated Fel d
1 (76.9 %) (Fig. 3a). One possible explanation for the de-
creased IgE-binding capacity in purified Asp f 1 is that con-
formational epitopes of Asp f 1 might be destroyed by
treatment with PC-ions to impair its IgE-binding capacity
without affecting protein amount. Although our data sug-
gest that induction of protein degradation is the predomin-
ant effect of PC-ions, another possibility that PC-ions
induce any structural changes in purified Asp f 1 (e.g. in-
duction of protein denaturation and/or aggregation) needs
to be addressed by further analysis.
PC-ions can be generated by the discharge of plasma in a
Plasma Cluster™ device. Plasma discharge can produce OH
radicals from atmospheric hydrogen oxide to generate H3O
+(H2O)n positive-cluster and O2
−(H2O)n negative-cluster
ions. It has been considered that charged PC-ions attach to
the protein surface, hydroxyl radicals appear on it as a re-
sults of chemical interactions between the ions, and degrade
it nonspecifically [17]. Neither NOx nor SOx are detectable
during the production of PC-ions by plasma discharge (data
not shown). There are several reports to show the degrad-
ation of protein and inactivation of virus by oxidation by
ozone, it can be cogenerated with PC-ions by plasma dis-
charge and other air-cleaning devices [18–20]. However, the
amount of ozone cogenerated with PC-ions from our de-
vices was negligible (less than 0.01 parts per million) and
considered not to affect the protein degradation, signifi-
cantly [17]. Therefore, we considered the degradation and
impairment of IgE-binding capacity of the allergens were
mediated by the generation of hydroxyl radicals produced
by generation of PC-ions neither by generation of ozone.
We previously showed capacity of PC-ions to inactivate
pollen allergens [3]. To further confirm the usefulness of
PC-ions on environmental control of allergens, here we
have focused on cat and fungal allergens, since those are
common and clinically important indoor allergens existed
throughout the year. Present data implicate that PC-ions
could be useful for inactivation of indoor allergens to avoid
clinical symptoms. The actual efficacy of PC-ions in normal
living conditions should be confirmed by future clinical
studies. In addition, the precise mechanisms whereby PC-
ions degrade and/or inactivate airborne allergens needs to
be further clarified.
Conclusion
In this present study, we showed that inactivation of crude
and purified airborne allergens by PC-ions in experimental
cylindrical apparatus could occur. We will need to establish
whether a PC-ions-generating device can degrade and in-
activate airborne allergens in indoor living spaces and
ameliorate allergic symptoms that can be elicited by air-
borne allergens in double-dummy, sham device-controlled,
randomized clinical studies. Together, our data suggests
that PC-ions can effectively inactivate a cat major allergen
and fungal allergens by reducing the amount of allergens
and impairment of their IgE-binding capacities.
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